{"id":"W2885787877","doi":"10.1158/1538-7445.am2018-3919","title":"Abstract 3919: Targeting urease to human VEGFR2 elicits antitumor activity in triple-negative breast cancer models","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Helix Biopharma (Canada)","funders":"","keywords":"Antibody; Flow cytometry; Cancer research; In vivo; Cancer; Cancer cell; Molecular biology; Chemistry; Biology; Immunology; Medicine; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000152262,0.0004103655,0.0004167102,0.0002419383,0.0001104814,0.0001975878,0.0002040009,0.0004113915,0.003137794],"category_scores_gemma":[0.00006805306,0.0001111038,0.0002309524,0.0001312259,0.0001493574,0.0001497496,0.0001210817,0.0005443242,0.0005640276],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003038337,"about_ca_system_score_gemma":0.0002442494,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000607832,"about_ca_topic_score_gemma":0.0007992226,"domain_scores_codex":[0.9998915,0.00001495046,0.000007834316,0.00001870286,0.0000307468,0.0000361479],"domain_scores_gemma":[0.9999502,0.000007736743,0.00001167406,0.000004780783,0.000005775299,0.00001985821],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002656791,0.0002104796,0.00006497627,0.00004434256,0.000007370677,0.00004192896,0.00001036085,0.00008307787,0.9973902,0.00007233967,0.0002516309,0.001557543],"study_design_scores_gemma":[0.0001291747,0.00285442,0.00143182,0.000007360234,0.00002003759,0.0002217152,0.000009740223,0.0008585964,0.9914415,0.00003203238,0.002989779,0.000003709873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926472,0.00122556,0.002225007,0.0001993373,0.00008448477,0.000137541,0.0008250424,0.0001913618,0.002464495],"genre_scores_gemma":[0.9874421,0.001024924,0.002405875,0.00009645623,0.00003574992,0.0001914274,0.001563275,0.00003044343,0.007209722],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003137794,"threshold_uncertainty_score":0.01049697,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06022259180128843,"score_gpt":0.4058734634823191,"score_spread":0.3456508716810306,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}